Placental Abruption: When Initial Hemorrhagic Shock Management Fails to Stabilize the Patient
In placental abruption with significant hemorrhage, initial resuscitation targets circulatory stability. When the first-line protocol does not achieve the required hemodynamic response, a more intensive escalation protocol is indicated.
The preceding protocol — transfusion of cross-matched packed red blood cells for Class 2 hemorrhagic shock (estimated blood loss 15–30%) — did not achieve stabilization of vital signs or heart rate below 100 bpm. This protocol addresses the next step after that failure.
This escalation protocol involves a more intensive blood product resuscitation strategy for Class 3 hemorrhagic shock, including components specifically directed at correcting coagulation deficits in addition to volume restoration. The complete regimen — product selection, sequencing, and monitoring intervals — is in the full protocol.
- Fibrinogen maintained above 50 to 100 mg/dL
- Platelet count maintained above 50 × 103 per microliter
- Stabilization of vital signs in response to resuscitation
DOI: 10.1016/j.ajog.2022.06.059
- Give 2 units cross-matched PRBC and 2 units FFP
- Fluid bolus
- Monitor for response in vitals
- Trend labs q4–6 hours
- Cryoprecipitate should be administered to ensure that the patient with abruption has fibrinogen levels of >50 to 100 mg/dL.
- In the context of active bleeding, platelets should be transfused to a goal of greater than 50×103 per mL.
- Its use is indicated when a pregnant patient with abruption is thought to have multiple acquired coagulation factor deficiencies, such as in cases of obstetrical hemorrhage treated with massive transfusion and in cases of DIC.